Investors in Edwards Lifesciences Corporation EW need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $45.00 Call had some of the highest...
Daniel J. Lippis, the CVP of $EW ($EW), sold 2,500 shares of the company on 12-16-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.7% of their shares. Following...
Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Scott B. Ullem, the CVP of $EW ($EW), sold 11,250 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 26.9% of their shares. Following...
Edwards Lifesciences has recently underperformed the broader S&P 500, yet analysts remain moderately optimistic about the stock's potential.
Daveen Chopra, the CVP of $EW ($EW), sold 1,750 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.0% of their shares. Following...
Edwards Lifesciences has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
Edwards Lifesciences: Q3 Earnings Snapshot
Edwards Lifesciences will release its third-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.11%. Stocks today are slightly...